Detalles de la búsqueda
1.
Event-free Survival with Pembrolizumab in Early Triple-Negative Breast Cancer.
N Engl J Med
; 386(6): 556-567, 2022 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35139274
2.
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium.
Mod Pathol
; 37(7): 100497, 2024 Apr 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38641322
3.
Designing clinical trials based on modern imaging and metastasis-directed treatments in patients with oligometastatic breast cancer: a consensus recommendation from the EORTC Imaging and Breast Cancer Groups.
Lancet Oncol
; 24(8): e331-e343, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37541279
4.
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy.
Breast Cancer Res
; 25(1): 32, 2023 03 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36978142
5.
Pembrolizumab for Early Triple-Negative Breast Cancer.
N Engl J Med
; 382(9): 810-821, 2020 02 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-32101663
6.
Autologous Reconstruction After Failed Implant-Based Breast Reconstruction: A Comparative Multifactorial Outcome Analysis.
Ann Plast Surg
; 91(1): 42-47, 2023 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37450860
7.
The Partner Perspective on Autologous and Implant-Based Breast Reconstruction.
Aesthetic Plast Surg
; 47(4): 1324-1331, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36820865
8.
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
Br J Cancer
; 126(12): 1715-1724, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35194193
9.
The Search for the Ideal Female Breast: A Nationally Representative United-States-Census Study.
Aesthetic Plast Surg
; 46(4): 1567-1574, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35043247
10.
70-gene signature as an aid for treatment decisions in early breast cancer: updated results of the phase 3 randomised MINDACT trial with an exploratory analysis by age.
Lancet Oncol
; 22(4): 476-488, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33721561
11.
Magnetic resonance imaging and ultrasound for prediction of residual tumor size in early breast cancer within the ADAPT subtrials.
Breast Cancer Res
; 23(1): 36, 2021 03 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-33736679
12.
Early response by MR imaging and ultrasound as predictor of pathologic complete response to 12-week neoadjuvant therapy for different early breast cancer subtypes: Combined analysis from the WSG ADAPT subtrials.
Int J Cancer
; 148(10): 2614-2627, 2021 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33533487
13.
The INTREST registry: protocol of a multicenter prospective cohort study of predictors of women's response to integrative breast cancer treatment.
BMC Cancer
; 21(1): 724, 2021 Jun 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34162339
14.
Gynecologists' attitudes toward and use of complementary and integrative medicine approaches: results of a national survey in Germany.
Arch Gynecol Obstet
; 303(4): 967-980, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33201377
15.
Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer.
Breast Cancer Res Treat
; 174(2): 453-461, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30603996
16.
Post-Mastectomy Radiotherapy After Neoadjuvant Chemotherapy in Breast Cancer: A Pooled Retrospective Analysis of Three Prospective Randomized Trials.
Ann Surg Oncol
; 26(12): 3892-3901, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31350646
17.
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study.
BMC Cancer
; 19(1): 611, 2019 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31227025
18.
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA).
Anticancer Drugs
; 30(4): 394-401, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30875348
19.
IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer.
Future Oncol
; 15(17): 1951-1961, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30977385
20.
Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy.
Lancet Oncol
; 19(1): 40-50, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29233559